baber/WOPTO huggingface dataset:
Patent DE-69914491-T2 (DE)
Inventor: KISHKOVICH OLEG
IPC: B01D53/04
Filed: 1999-08-20
Granted: 2004-12-02
Abstract: A clean, high efficiency, low pressure drop, adsorptive filter material that is porous and includes an acidic functional group. The filter can include, for example, a non-woven filter composite has a porous sulfonated divinyl benzene styrene copolymer beads having sulfonic acid functional side groups. The non-woven filter is used to remove molecular bases, including ammonia, organic amines, inides, aminoalcohols, alcoholoamines from the atmosphere used in semiconductor fabrication and other processes that require uncontaminated gaseous environments of high quality.
Patent DE-69916277-T2 (DE)
Inventor: IMMONEN OLLI
IPC: G06K19/00
Filed: 1999-07-02
Granted: 2005-03-10
Abstract: A wireless device, such as a cellular phone, connects to a separate unit, such as a smart card, holding secure connection data. A data device receives a request and chooses a cryptation algorithm, associated with a public and a private key, and transmits a message back (100-105). The cellular phone generates a master secret code (106) and calculates a signature. When the data device receives a respond it extracts the master code to establish a secure connection (107-113). An independent claim is also included for a wireless communication system for establishing a secure connection to a data communication system based on a wireless application protocol and using a smart card or a subscriber identity module.
Patent DE-69930926-T2 (DE)
Inventor: BUTLIN ROGER JOHN
IPC: C07D521/00
Filed: 1999-03-11
Granted: 2007-01-25
Abstract: Compounds of formula (I), pharmaceutically acceptable salts or in vivo hydrolysable esters thereof, wherein: Ring X is phenyl or a six membered heteroaryl ring containing one or two ring nitrogens where said nitrogens are optionally oxidised to form the N-oxide; R<1 >and R<2 >are substituents as defined within; R<3 >and R<4 >are defined within and are alkyl or halo alkyl or together form a halocycloalkyl ring; R<5 >is a substituent as defined within; Y-Z is a linking group as defined within; are useful in the production of a elevation of PDH activity in a warm-blooded animal such as a human being. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are described.
Patent HU-E027508-T2 (HU)
Title: 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
Inventor: LABRIE FERNAND
IPC: C07J63/00
Filed: 2008-04-11
Abstract: Compounds having the structure, their salts or N-oxide derivatives: are used to treat or reduce le likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. They can be formulated together with pharmaceutically acceptable diluent or carrier or otherwise made into any pharmaceutical dosage form. Combinations with other active pharmaceutical agents are also disclosed.
Patent HU-E029601-T2 (HU)
Title: Broadcast signal transmitter and receiver, and broadcast signal transmitting and receiving method
Inventor: KO WOO SUK
IPC: H04B7/04
Filed: 2011-02-01
Abstract: According to one embodiment of the present invention, a broadcast signal transmitter comprises: an FEC encoder which performs FEC encoding on data; a demultiplexer which reorders the bit order of the FEC-encoded data; a divider which reorders the reordered bits in accordance with the QAM types of a first input signal and of a second input signal so as to output the first input signal and the second input signal; a first symbol mapper and a second symbol mapper which perform symbol-mapping on the first input signal and on the second input signal so as to generate M-QAM symbol signals, respectively; a first frame builder and a second frame builder which build the frame structures of the first input signal and of the second input signal, respectively; a MIMO encoder which performs MIMO processing on the first input signal and on the second input signal to output an M*M-QAM-type first transmission signal and a M*M-QAM-type second transmission signal; and a first OFDM generator and a second OFDM generator which perform OFDM modulation on the first transmission signal and on the second transmission signal, respectively.
Patent SI-1651213-T2 (SI)
Title: Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity
Inventor: KAUSCHKE STEFAN
IPC: A61P9/12
Filed: 2004-07-24
Abstract: Angiotensin II receptor antagonist is used to prepare a medicament for treating people for whom type 2 diabetes has been diagnosed or prediabetes is suspected, for preventing diabetes or for treating metabolic syndrome and insulin resistance in patients with normal blood pressure. An independent claim is also included for a composition comprising telmisartan in combination with: amlodipine or nifedipine; eplerenone or spironolactone; simvastatin or atorvastatin; rosiglitazone, pioglitazone, repaglinide or metformin; dipyridamol or clopidogrel, optionally in combination with aspirin; an aldosterone antagonist; a HMG-CoA reductase inhibitor; a dipeptidyl peptidase 4 inhibitor; a sulfonylurea; or a thrombocyte aggregation inhibitor. ACTIVITY : Antidiabetic. MECHANISM OF ACTION : Angiotensin II Receptor Antagonist; Peroxisomal Proliferator Activated Receptor Gamma (PPARgamma) Activator. PC12W cells overexpressing PPARgamma 2 and its heterodimer partner RXRalpha were treated with telmisartan (10 MicroM). PPARgamma activity was increased by a factor of 1.9.
Patent TR-200101695-T2 (TR)
Inventor: ESTANOVE CYRIL
IPC: A61K31/7042
Filed: 1999-12-10
Abstract: The invention concerns novel troxerutin with high trihydroxy-ethyl-rutin content. Said troxerutin has at least 92 wt. % of 7,3',4'-trihydroxyethyl rutin and a wettability expressed in minutes less than 10 minutes, when said wettability is measured in a test consisting in measuring the time taken by 3.5 g of said enriched troxerutin powder to leave the surface of a beaker containing 100 ml of water, at a stabilised temperature of 20° C., when said enriched troxerutin powder is poured at the surface of the water in said beaker, and a wettability less than 100 seconds when said wettability is measured in a test consisting in measuring the time taken by said enriched troxerutin to be wetted by the water contained in a receptacle, such as a beaker, when said enriched troxerutin has been deposited at the surface of the water, in the form of cores of 2 mm wide and 3 mm high weighing 63 ? 2 mg, at a stabilised temperature of 20° C. Said troxerutin has improved properties of wettability and solubility in water.
Patent TR-200103548-T2 (TR)
Inventor: RIESOP JOERG
IPC: C23C22/73
Filed: 2000-07-06
Abstract: The invention concerns a method for chemical treatment of metal strips which consists in applying unilaterally or bilaterally a treating liquid on the surface of metal strips using a roller coater, and in drying said liquid without intermediate rinsing. Said method is characterised in that it consists in using a lap roll as roller coater. The treating liquid is preferably a phosphating solution, a chromating solution, an acid or alkaline passivating solution, a treating solution based on complex fluorides or a solution or dispersion of an organic film-forming agent.
Patent DE-602004005275-T2 (DE)
Inventor: LOWLES ROBERT J
IPC: H04N5/58
Filed: 2004-08-05
Granted: 2007-12-20
Abstract: A method and system for automatically adjusting a backlight intensity level for displays is disclosed. The system and method are implemented in electronic devices having a camera and digital backlit displays, such that the camera is used to determine an ambient light level and the backlight level is adjusted according to the determined ambient light level. In particular, when the camera is not in use for capturing images by the user, the automatic backlight adjustment system captures a first image with the camera to determine an initial ambient light level, and then captures a second image with the camera at a later time to determine a subsequent ambient light level. The subsequent and initial ambient light levels are compared to each other and the backlight intensity level is either increased or decreased a predetermined amount for optimal viewing and low power consumption. Backlight intensity determination can be performed on the basis of a single image instead of a differential between two images.
Patent DE-602004005718-T2 (DE)
Inventor: PIACENTINI SERGIO
IPC: H04B1/69
Filed: 2004-11-04
Granted: 2007-12-27
Abstract: A method of communicating information comprises the steps of generating a plurality of power pulses (3) the time spacing of which is modulated by the information to be transmitted, and transmitting said power pulses (3) to a radio receiver (2). The power pulses (3) are generated through a plurality of carrier signals (4) modulated by modulation pulses (5). The method in reference has features of low energy consumption and high rejection of the Doppler effect. The occupied bandwidth can adapt itself to the requirements imposed by the regulations in force for the different usable frequency ranges.
Patent DE-602004005731-T2 (DE)
Inventor: BRUEL MICHEL
IPC: C30B33/02
Filed: 2004-09-23
Granted: 2007-12-27
Abstract: Method for fabricating a structure in the form of a plate, and structure in the form of a plate, in particular formed from silicon, including at least one substrate, a superstrate and at least one intermediate layer interposed between the substrate and the superstrate, in which the intermediate layer comprises at least one base material having distributed therein atoms or molecules termed extrinsic atoms or molecules which differ from the atoms or molecules of the base material, and in which a heat treatment is applied to said plate so that, in the temperature range of said heat treatment, the intermediate layer is plastically deformable and the presence of the selected extrinsic atoms or molecules in the selected base material causes the irreversible formation of micro-bubbles or micro-cavities in the intermediate layer.
Patent DE-602004007066-T2 (DE)
Inventor: IWAYAMA KAZUYOSHI
IPC: B01J35/00
Filed: 2004-07-05
Granted: 2007-09-27
Abstract: A catalyst in which X-ray diffraction intensity ratio of the crystal lattice plane spacing d-value of 0.1196+/-0.002mm to the crystal lattice plane spacing d-value of 0.386+/-0.008nm is in a range from 100 : 7 to 100 : 35 and a process for converting ethylbenzene containing xylenes in the presence of hydrogen with said catalyst. <IMAGE>
Patent DE-602004008216-T2 (DE)
Inventor: HOLTZMAN JACK M
IPC: H04B7/005
Filed: 2004-01-16
Granted: 2008-05-15
Abstract: Techniques for improved margin control in a data communication system are disclosed. In one aspect, margin is adjusted in response to a first subpacket error rate (350). In another aspect, margin is further adjusted in response to an overall packet error rate (350). In yet another aspect, the first subpacket error rate is adjusted in response to an overall packet error rate (350). Various other aspects are also presented. These aspects have the benefit of responsive margin control when the overall packet error rate is relatively low, resulting in improved data throughput and increased system capacity.
Patent DE-602004011330-T2 (DE)
Inventor: HEMMERLING MARTIN
IPC: C07D471/04
Filed: 2004-05-06
Granted: 2009-01-15
Abstract: The present invention relates to imidazo and thiazolopyridine compounds of formula (I) which are kinase inhibitors, methods for their preparation intermediates and pharmaceutical compositions comprising them.
Patent DE-602005000987-T2 (DE)
Inventor: YATA KUNIO
IPC: H04N5/232
Filed: 2005-12-28
Granted: 2008-01-17
Abstract: The present invention provides an auto focus system capable of having an AF area (42) which is a target range of auto focus (AF) automatically follow a follow-up target subject as a focusing target, wherein the system changes a size of a range for capturing an image of the follow-up target subject as a reference pattern image out of the range of a photographing image according to a target subject distance and a focal length of a photographing lens (50) so as to appropriately perform detection of the image of the target subject and automatic follow-up of the AF area (42) even in the case where the size of the image of the target subject in the photographing image of the camera changes such as the case where the distance between the camera and the follow-up target subject changes or the case where the focal length of the photographing lens (optical system (12) of the camera) changes.
Patent DE-602005001059-T2 (DE)
Inventor: LERNOUT HANS
IPC: F24F11/75
Filed: 2005-01-31
Granted: 2008-01-17
Abstract: The invention relates to a device for regulating the airflow rate in a ventilation device (1a, 1b), comprising an autonomously operating valve (2) movably provided in an air duct (3) of the ventilation device (1a, 1b) and which automatically adjusts the airflow opening with relation to the pressure difference between the inlet (4) and the outlet (5) of the air duct (3), in which the valve (2) is rotatingly suspended around a free suspension point (6) in the air duct (3), and provided in such a way that, upon rising pressure difference, the valve (2) moves in the air duct (3) first by rotating to a maximum turning angle around the free suspension point (6) and subsequently by deforming, without further rotation around the free suspension point (6). <IMAGE>
Patent DE-602005001772-T2 (DE)
Inventor: FREEMAN ALAN JOHN
IPC: F04B9/117
Filed: 2005-02-15
Granted: 2008-06-05
Abstract: A pressure intensifier assembly comprising:-(i) a high-pressure barrel assembly; (ii) pressurizing means; (iii) a first and a second end closure assembly; (iv) a tension frame assembly adapted to resist axial load exerted, in use, along the longitudinal axis of the high-pressure barrel assembly; characterised in that the intensifier assembly further comprises at least one clamping piston adapted to preload the end closure(s) and the high-pressure barrel assembly against the tension frame assembly in order to overbalance anticipated internal end loads.
Patent DE-60016007-T3 (DE)
Inventor: BERGER ALVIN
IPC: A61K31/20
Filed: 2000-09-14
Granted: 2009-07-09
Abstract: A nutritional or therapeutic composition for oral administration which comprises a naturally occurring precursor that is metabolised to a compound having anandamide activity for use as a medicament or nutritive product. In addition the invention includes a method of production of the composition, use of the composition in the manufacture of a nutritional composition for the treatment or prevention of a behavioral disorder; and a method of treatment or prevention of a behavioral disorder which comprises administering an effective amount of the composition. In a preferred embodiment the composition comprises a triacylglycerol having palmitate and arachidonate attached to its backbone wherein arachidonate is at the sn-1 and sn-2 positions.
Patent DE-68905217-T3 (DE)
Inventor: BITON JACQUES
IPC: A23L33/20
Filed: 1989-04-13
Granted: 1997-02-06
Abstract: The invention relates to a method intended for reducing the total daily energy intake in man or animals, wherein one or more fructosyle oligosaccharides containing from 3 to 8 glycoside units linked via beta bonds replace all or part of the energy-rich sugars in products intended for feeding or for dietetic purposes. 
<??>The invention also relates to nutritional or dietetic products or beverages, wherein the energy-rich sugars which they contain are wholly or partially replaced by such fructosyle oligosaccharides.
Patent DE-69013453-T3 (DE)
Inventor: PEARSON STEPHEN FORBES
IPC: B41J2/045
Filed: 1990-08-20
Granted: 1999-08-05
Abstract: A three component refrigerant composition for use in vapour compression refrigerators and avoiding the use of ozone-depleting chlorofluorocarbons comprises a three component mixture of:   (i) a major portion comprised of chlorodifluoromethane (R22) or pentafluoroethane (R125);   (ii) R125 or octafluoropropane (R218); and   (iii) propane in non-flammable proportions.o
Patent DE-69123359-T3 (DE)
Inventor: THOMAS GRAHAM
IPC: H04N7/36
Filed: 1991-09-20
Granted: 2000-06-08
Abstract: The appropriate one of a list of possible motion vectors is applied to each region of a video image. An image value for that region is determined for each of four successive fields, for each of the possible motion vectors. The values for these four fields are compared and when the values are substantially the same for a given vector it is assumed that is the vector appropriate to that region. The vectors appropriate to regions of obscured or revealed background can also be assigned by comparing inter-field differences and determining regions where the inter-field differences are high for the central pair and one outer pair and low for the other outer pair of fields. To generate regions corresponding to obscured background only information from the earlier fields is used and to generate regions corresponding to revealed background only information from the later fields are used.
Patent DE-69312116-T3 (DE)
Inventor: BONIN YVES
IPC: C08K3/00
Filed: 1993-02-17
Granted: 2003-12-11
Abstract: Polyamide-based composition made flame-resistant with red phosphorus.   More particularly a composition comprising a zinc compound such as a zinc oxide, a zinc borate and/or a zinc sulphide to reduce the corrosiveness of the composition towards metals or alloy and to decrease the phenomena of migration of the components from the composition. It is intended more particularly for the production of moulded articles.
Patent DE-69330027-T3 (DE)
Inventor: SHORTLE R
IPC: C12N15/09
Filed: 1993-04-13
Granted: 2008-09-25
Abstract: A new technique for generating mixtures of oligonucleotides in a single automated synthesis is taught. The method can be used to prepare mixed oligonucleotides ideally suited for creation of useful mixtures of oligo- or polypeptides or proteins. Additionally, the technique enables insertion and/or substitution and/or deletion of a nucleotide sequence at one or more sites. For protein mutagenesis, a trinucleotide can be inserted or substituted at codon boundaries. The invented technique makes possible the encoding of all possible single amino acid insertions, or any desired mixture of substitutions and insertions.
Patent DK-1069372-T3 (DK)
Inventor: JOHANSSON JOERGEN
IPC: F21V11/02
Filed: 2000-07-03
Granted: 2004-12-27
Abstract: The invention relates to an anti-dazzle screen (26) for a lighting fitting, which comprises two reflector sides (2) opposite each other and lamellas (1), which are compressible per Se, connect said reflector sides with each other and are made of double sheet material. The reflector sides (2) have recesses (6), into which the gable ends (13) of the lamellas will be inserted, and there are means (24, 25) designed to fasten the lamellas to said recesses. According to the invention said gable ends (13) are fastened in an expanded condition at the reflector sides (2) and will fill said recesses (6) in a non-compressible condition. The gable ends have tongues (15) outside the reflector sides, which are directed against each other in order to secure the expanded position of the lamellas in the recesses in the reflector sides (2). The invention also relates to a method of assembling an anti-dazzle screen according to claim 1, which is characterized in that said gable ends (13) are fastened in an expanded condition at the reflector sides (2) and consequently will fill said recesses (6) in a non-compressible way. <IMAGE> <IMAGE>
Patent DK-1146896-T3 (DK)
Inventor: NG KINGMAN
IPC: A61K47/26
Filed: 2000-01-26
Granted: 2002-09-02
Abstract: The present invention provides formulations and methods for preparing formulations containing an aqueous solution at a pH of greater than about 7.9. The aqueous solution includes an isotonicity agent, a phenolic derivative, zinc ions, and an acylated human insulin analog. More particularly, the invention relates to formulations having a pH of greater than about 7.9 that include a monoacylated human insulin analog such as an acylated des(B30) human insulin analog or an analog that comprises a native or modified human insulin A chain optionally modified at position A21, and a modified native human insulin B chain optionally modified at position B3 and modified at position B28, or at both positions B28 and B29, and that contains a lysine residue at either position B28 or B29 acylated with a fatty acid residue. The invention also provides a method for treating a patient suffering from hyperglycemia using the pharmaceutical formulations of the invention.
Patent DK-1206257-T3 (DK)
Inventor: RIBES GERARD
IPC: A61P3/04
Filed: 2000-08-23
Granted: 2005-03-14
Abstract: Use of a mono- or poly-hydroxylated amino acid and/or a lactone of these, in medicines for the treatment of insulin resistance.
Patent DK-1218603-T3 (DK)
Inventor: GREGG F BROWNE
IPC: B32B13/14
Filed: 2000-10-06
Granted: 2003-09-22
Abstract: A system for making wallboard or backerboard sheets may include a mixer for mixing materials for making aerated concrete, at least one face layer supply, and a former downstream from the mixer. The former is for forming core material having opposing first and second major surfaces and comprising aerated concrete, and for securing at least one face layer from the at least one face layer supply onto at least one of the first and second major surfaces of the core material. The system may also include a cutter downstream from the former for cutting the core material and at least one face layer secured thereto into a plurality of wallboard or backerboard sheets. The provision of aerated concrete for the core provides many key advantages over conventional gypsum wallboard sheets, and/or conventional backerboard sheets, such as gypsum greenboard or cementitious backerboard, for example. In one class of embodiments, the former may further include an autoclave for curing the core material prior to securing the at least one face layer thereto. In another class, the former may further include an autoclave for curing the core material after securing the at least one face layer thereto.
Patent DK-1230381-T3 (DK)
Inventor: KAWASAKI GLENN
IPC: C12Q1/32
Filed: 2000-11-02
Granted: 2011-10-31
Abstract: The present invention provides an enzymatic cycling assay for assessing the amount of homocysteine and/or cystathionine in a solution such as blood, blood, derivatives, or urine. The assay comprises the steps of contacting the solution containing homocysteine and/or cystathionine to form a reaction mixture, with CBS, or a derivative thereof, L-serine, and CBL, or a derivative thereof, for a time period sufficient to catalyze the cyclical conversion of homocysteine form to cystathionine and the reconversion of cystathionine to homocysteine with the production of pyruvate and ammonia; determining the amount of homocysteine and/or ammonia present in the reaction mixture; and determining the amount of homocysteine and/or cystathionine present in the solution based on the amount of pyruvate and/or ammonia formed. Expression vectors and isolation procedures for CBS, or derivatives thereof, and CBL, or derivatives thereof, are also provided as well as test kits for carrying out the assay. In preferred embodiments, the assays can be conducted in 15 minutes or less, with a minimum of enzyme usage.
Patent DK-1156043-T3 (DK)
Inventor: LYNCH GARY S
IPC: C07D317/60
Filed: 1993-07-23
Granted: 2004-03-01
Abstract: Use of a drug that enhances the functioning of the AMPA receptor :for the manufacture of a medicament for enhancing the functioning of said receptor to enhance intellectual performance or memory encoding.